Tom Brady’s Dog Cloning Sparks Ethical Debate
- Colossal Biosciences acquired Viagen, a leader in animal cloning technology.
- Tom Brady revealed his dog Junie is a genetic clone of his late dog Lua.
- Critics raise ethical concerns about cloning, citing animal welfare and high failure rates.
- PETA and ASPCA criticize the practice, urging adoption over cloning.
The acquisition of Viagen by Colossal has intensified discussions around pet cloning, especially after Tom Brady’s announcement about his cloned dog Junie. Critics argue that cloning raises significant ethical issues, with organizations like PETA and ASPCA calling for more regulation and promoting adoption instead.
Despite assurances from Colossal about the health of cloned animals, concerns persist regarding the industry’s transparency and the welfare of animals involved in failed attempts. Source
